chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she received more than the standard dose; tired; chest pain when she took a breath; This is a spontaneous report from a contactable consumer or other non hcp. A 28-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection), via an unspecified route of administration on 15May2021 (Lot Number: EW0176, at the age of: 28-year-old) as dose 2, single for COVID-19 immunisation. There were no medical history and concomitant medication. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection), via unspecified route of administration on 22Apr2021 (Lot Number: ER8731, at the age of: 28-year-old) as dose 1, single for COVID-19 immunisation. It was reported that she first got the shot and then a little bit later they went to a late lunch, and she was sitting there and said her chest was hurting and she was starting to get worried, it was the middle of her chest. When she breathed in, she said it will be okay. She told her that also happened to the caller's father-in-law, he had some chest pain after his shot and later on he was okay after that she was tired. It was not any bad reaction. She was a healthy person, she told her daughter to get up and walk around maybe its gas but that didn't help, she was having some chest pain, but it did go away and so far she has been okay. She just told her daughter grandpa had it too and it went away. She was trying to understand, she was not a nurse, so she did not understand stuff like that. The pharmacy did not say how much her daughter was given, she thought it was minimal, not like a double dose anything but it was more than what would be the standard dosage, she was not sure how much it was, and she did not want to say because she could not remember. She thinks the pharmacy would have had to document it too, that she got more. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
This does not give the option to say that each vaccine I received caused symptoms.  I have now had my second booster as well.  I had the common symptoms of high fever above 102, headache, nausea, abdominal pain including bladder, fatigue, ache all over, extreme shivering chills for about 12 hours.  Then was left with fatigue and achiness for three weeks.  The side-effect worth noting is a recurrence of leg weakness causing an inability to walk right.  This happened in 2005-2006.  No diagnosis was ever given and it went away on its own.  It did recur until about a week after my first vaccine.  It settled down until the boosters I received on 11/02/.2021 and the second on 05/26/2022.  This last time it was more severe, but strength returned mostly after five days.  Too soon to tell if it is completely gone, but my past experience is that it no longer goes away completely, but shows up especially when I'm fatigued.
patient was given 2nd dose of Moderna 17 hours after vial was opened; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was given 2nd dose of Moderna 17 hours after vial was opened) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, LOSARTAN and TRAZODONE for an unknown indication.    On 31-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was given 2nd dose of Moderna 17 hours after vial was opened). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was given 2nd dose of Moderna 17 hours after vial was opened) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient has not reported any adverse events so far.
RED ITCHY BURNING BUMPS SPREAD TO HANDS AND LEGS; RED ITCHY BURNING BUMPS ON STOMACH; This spontaneous report received from a patient concerned a 58 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-APR-2021, the subject experienced red itchy burning bumps on stomach. On 15-APR-2021, the subject experienced red itchy burning bumps spread to hands and legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red itchy burning bumps on stomach, and red itchy burning bumps spread to hands and legs. This report was non-serious.
COVID-19 INFECTION; This spontaneous report received from a patient male. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received bnt 162 (Dose number in series was 1) (form of admin, route of admin, and batch number were not reported) dose was not reported, administered on an unspecified date in APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with bnt 162 (Pfizer). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series was 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: UNKNOWN) dose was not reported, 1 total, administered on 29-DEC-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced covid-19 infection (Dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 infection was not reported. This report was non-serious. This report was associated with product quality complaint 90000210119. The suspected product quality complaint has been confirmed to be voided (did not meet Regulatory Authority criteria since infection occurred less than 14 days after receiving the booster shot) based on the Regulatory Authority evaluation/investigation performed.
Pt complained of light headed, diaphoretic, vision went blank. Pt calmly placed on flat surface with legs elevated. VS checked.
Hematoma at injection site (brown skin discoloring). No pain or itching. Pt presented 5 days after injection administered.
At 1:34pm employee states was feeling a little nauseated. Several minutes later employee had the urge to vomit. She went to vomit in women's restroom. Per employee vomited a little bit it was yellow. Donor states might have been her lunch (12:20). After vomiting she felt better no longer feeling nauseated.
I headache characterized by a numbness/tingling/throbbing pain above hairline.  It has lasted and is still presenting one week post-vaccination.
Nurse vaccinated a patient 4 days before her second dose was due; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Nurse vaccinated a patient 4 days before her second dose was due) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Nurse vaccinated a patient 4 days before her second dose was due). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Nurse vaccinated a patient 4 days before her second dose was due) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
pt recv vax 7APR95 & 5MAY95 pt presented to ER w/hx of inc bruising & petechiae 2wk p/ a viral gastroenteritis;exp h/a, rash, stiff neck, palatal & tongue petechiae;dx meningitis, ITP, allerg dermatitis;also inc facial flushing;itchiness;
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2020 as dose 1, single (Lot number: EK5730), in left arm, on 05Jan2021 as dose 2, single (Lot number: EK9321), in left arm and on 25Sep2021 as dose 3 (booster), single (Lot number: 3014584) at the age of 36 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MIRENA, start date: 01Dec2020. Patient received the other medication in 2 weeks. Other medication in 2weeks product included Mirena intrauterine device. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" (30Apr2022) and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Symptoms worse than COVID symptoms in the first 5days while on paxlovid; (30Apr2022) Negative, notes: Tested negative on home COVID antigen test on day 7. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Rebound symptoms. Developed URI symptoms - sneezing, nasal congestion, sinus pressure, body aches, sore throat 11 days after initial positive COVID test. Symptoms worse than COVID symptoms in the first 5 days while on Paxlovid. Tested negative on home COVID antigen test on day 7. Patient received the treatment Paxlovid start from 24Apr2022 and treatment stop on 28Apr2022 for event COVID-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information and the known product safety profile a causal relationship between the reported events, COVID 19, Drug Ineffective and BNT162B2 is considered possible.
Arm soreness; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient stated he did not take any medication and did not visit his HCP. It is unknown if the patient received the 2nd planned dose scheduled on 08APR2021.
4-16-21 @ 2PM SHE HAD A 'SHADOW IN HER RT EYE'. DROVE TO ER. DX WITH CLOT TO RT EYE AND LT OCCIPITAL AREA OF BRIAN. NO SURGERY. WAS GIVEN PLAVIX. HAS APPT WITH EYE DOCTOR ON MAY 3RD. SAW A NEUROLOGIST AND PCP. SHE IS DOING BETTER NOW AND RT EYE HAS 'CLEARED UP'. WILL NOT BE GETTING SECOND DOSE.
Information has been received from a Registered Nurse referring to a 7 month old patient of unknown gender. Information about patient's concurrent conditions and medical history was not reported. On 22-JUN-2015 the patient was vaccinated with a dose of improperly stored PEDVAXHIB (route not reported, lot # reported as K025004, dose 0.5 (unit not provided)). Concomitant medications were not provided. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a nurse referring to a 15 year old male patient. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unspecified date in June 2016, the patient was vaccinated with the first dose of GARDASIL 9 for prophylaxis (dose, route, lot # and expiration date were not reported). On an unspecified date in August 2016, the patient was vaccinated with the second dose of GARDASIL 9 for prophylaxis (dose, route, lot # and expiration date were not reported). On an unspecified date in September 2016, the patient was vaccinated with the third dose of GARDASIL 9 for prophylaxis (dose, route, lot # and expiration date were not reported). It was stated that the third dose was given earlier that the recommended for GARDASIL 9 series. No adverse effects were reported. A product quality complaint was not involved. Additional information is not expected because the reporter refused additional contact.
CHEST PAIN; SOB; ELEVATED INFLAMATORY MARKERS; ELEVATED TROPONIN; MYOCARDITIS
high fever 101 or something; her armpits and lymph nodes were very swollen.; her hand was kind of heavy; This is a spontaneous report from a contactable nurse (patient) reported that a 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration on the left arm on 28Jan2021 at a single dose for Covid-19 immunization. The patient medical history included that she was diabetic, and she have had COVID and she have been in long term for COVID from Jul2020 and unknown if ongoing. Concomitant medication included metformin. The patient received the vaccine on Thursday morning (28Jan2021) and the next day (29Jan2021), her hand was kind of heavy and that night through Saturday (30Jan2021). On an unspecified date, the patient spike very high fever 101 (no unit reported) or something all through non-stop; her armpits and lymph nodes were very swollen. As treatment, patient took Tylenol for the events. The outcome of her hand was kind of heavy was recovered on 30Jan2021, high fever 101 or something was unknown, and armpits and lymph nodes were very swollen was not recovered. The patient stated that she would like to be tested for her immunity before receiving her second dose since she thought that she still have low immunity from Jul2020 because she have been in very long term of Covid.
Patient reports that she took the shot on Monday morning, 8/2/21. On night of 8/3/21, she noticed  numbness and tingling to both sided of her body, arms and legs. Symptoms are mostly to left side. Pt recieved injection in her left arm. Arm a little sore in the area. Patient had video visit with her primary  care physician on 8/04/21. Physician notes indicate pt having some myalgias after the COVID vaccine with mild numbness in the arm where the shot was given. Diagnosis of Adverse effect of COVID-19 vaccine, plan of Aleve Bid and return if symptoms worsen or fall to improve.
Feeling of achiness, malaise, fatigue/tiredness starting the day after vaccination with second dose. Acetaminophen to treat.
the morning after her vaccine, her daughter noticed a rash on her left hip with red blisters. Noted Sat 1/9/2021. She was seen in my office on 1/13/2021 and I diagnosed her with shingles. Rash had spread over the 4 days to a dermatomal distribution from left mid back around to left mid abdomen. She had received the Zostavax vaccine in 2007.
I developed worsening tinnitus after receiving the booster dose of Covid19 - Pfizer-BioNTec Vaccine. I noticed tinnitus after my second dose given on 1/7/2021 of Pfizer. After the 3rd dose I have experienced a constant higher pitched tinnitus. The symptoms have become bothersome and interferes with my normal hearing. It has also interfered with my concentration and sleep.
I received the Moderna vaccine on Monday 1/11/21. There was swelling and pain at the injection site which lasted about 4 days. There was NO redness or rash at the injection site for a week. On 1/18/21 in the evening, suddenly a rash appeared which was warmer than the surrounding area. It was tender and about the size of a half dollar. It rapidly grew in size, on 1/20/21 it is now about 3x3.5 inches across and is still growing. I have called the Public Health Dept where I got the vaccination, without getting a response (3 times). I called Moderna, and was given a case Number: MOD21-09316. Batch number was 025J20-2A. They were not able to tell me anything beyond what I could read online. (It is odd that my injection site reaction was delayed a week.) I emailed my doctor and attached a photo. I am waiting to hear back.
I woke up at 6 AM and my ears are ringing constantly and it will not stop just got my shot yesterday at 2:45 I imagine this is because of the COVID-19 Pfizer shot. I fine before I got my vaccination and yesterday after I got my vaccination it was just this morning when this started
Cardio pulmonary; Completely out of energy; He is sleeping more then usual; Snoring; Cardiopulmonary event; After the second dose he was very sick for 3 days; Light fever; Ache all over; Left deltoid at the injection site hurt a lot; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Cardio pulmonary) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (Cardio pulmonary) (seriousness criterion medically significant), ASTHENIA (Completely out of energy), SOMNOLENCE (He is sleeping more then usual), SNORING (Snoring), LUNG DISORDER (Cardiopulmonary event), ILLNESS (After the second dose he was very sick for 3 days), PYREXIA (Light fever), MYALGIA (Ache all over) and VACCINATION SITE PAIN (Left deltoid at the injection site hurt a lot). At the time of the report, CARDIAC DISORDER (Cardio pulmonary), ASTHENIA (Completely out of energy), SOMNOLENCE (He is sleeping more then usual), SNORING (Snoring), LUNG DISORDER (Cardiopulmonary event), ILLNESS (After the second dose he was very sick for 3 days), PYREXIA (Light fever), MYALGIA (Ache all over) and VACCINATION SITE PAIN (Left deltoid at the injection site hurt a lot) outcome was unknown.            Patient was taking other medication.   Patient reported that he experienced sleep all night now he was sleeping 9:30 to 10 hours of sleep, he could not run half mile for like 4 months. But now he can run again.   No treatment medication information was mentioned by reporter; Sender's Comments: This case concerns a 67 year old male patient with no relevant medical history, who experienced the expected event of cardiac disorder. The event occurred on an unknown date after the second dose of mRNA-1273 vaccine. The rechallenge was unknown. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Second dose had not been administered yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received around 5 years before date of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Second dose had not been administered yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 21-SEP-2023 Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The reporter did not consent to follow up.
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. Information regarding the patients' medical history, concurrent condition and concomitant medication was not reported. On unknown dates in 2016 (reported as since 01-JAN-2016), the patients were vaccinated with improperly stored doses of GARDASIL (dose and route were not reported, lot# L007560, expiration date 15-JUN-2017). No adverse effects had been reported. The GARDASIL vaccines underwent the temperature excursion of -3 Celsius degrees for 19 hours. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Covid positive; Covid positive; I have serious side effects, I feel like I am about to die after I took your shot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid positive"; ANXIETY (medically significant), outcome "unknown", described as "I have serious side effects, I feel like I am about to die after I took your shot".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Exactly 48 hrs after 1st dose of Pfizer COVID-19 vaccine I began having heartburn.; Acid reflux is not something I suffer from regularly; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EP6955, Expiry date: not reported, age at vaccination: 35-year-old), via an unspecified route of administration, administered in Arm Right on 18Mar2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. No medical history was reported. The patient had no known allergies. Concomitant medications included temazepam (TEMAZEPAM) taken for an unspecified indication, start and stop date were not reported; lorazepam (ATIVAN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks of covid-19 vaccination. The patient did not have covid prior vaccination and was not tested for covid post vaccination. On 20Mar2021 at 15:00, exactly 48 hrs after 1st dose of pfizer covid-19 vaccine the patient began having heartburn, acid reflux was not something she suffer from regularly which kept her up all night. The patient started antacid over the counter meds today (24 hrs after the onset of symptoms) as corrective therapy and still no relief. The patient have not contacted her Dr yet as today is a Sunday. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.